Articles dans des revues avec comité de lecture (170)
78.
Delporte, C., Zouaoui Boudjeltia, K., Noyon, C., Furtmueller, P. G., Nuyens, V., Slomianny, M.-C., Madhoun, P., Desmet, J.-M., Raynal, P., Dufour, D., Koyani, C. N., Reye, F., Rousseau, A., Vanhaeverbeek, M., Ducobu, J., Michalski, J.-C., Neve, J., Vanhamme, L., Obinger, C., Malle, E., & Van Antwerpen, P. (2014). Impact of interaction between myeloperoxidase and low-density lipoprotein on the specific activity of the enzyme and subsequent post-translational oxidative modifications of apolipoprotein B-100. Journal of lipid research. doi:10.1194/jlr.M04744979.
Daher, J., Martin, M., Rousseau, A., Nuyens, V., Fayyad Kazan, H., Van Antwerpen, P., Courbebaisse, G., Martiat, P., Badran, B., Dequiedt, F., Zouaoui Boudjeltia, K., & Vanhamme, L. (2014). Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries. Mediators of inflammation, 2014, 134635. doi:10.1155/2014/13463580.
Nzeusseu Toukap, A., Delporte, C., Noyon, C., Franck, T., Rousseau, A., Serteyn, D., Raes, M., Vanhaeverbeek, M., Moguilevsky, N., Neve, J., Vanhamme, L., Durez, P., Van Antwerpen, P., & Zouaoui Boudjeltia, K. (2014). MYELOPEROXIDASE AND ITS PRODUCTS IN SYNOVIAL FLUID OF PATIENTS WITH TREATED OR UNTREATED RHEUMATOID ARTHRITIS. Free radical research. doi:10.3109/10715762.2014.88632781.
Boufadi, Y. M., Soubhye, J., Riazi, A., Rousseau, A., Vanhaeverbeek, M., Neve, J., Zouaoui Boudjeltia, K., & Van Antwerpen, P. (2014). Characterization and antioxidant properties of six algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity. International journal of molecular sciences, 15(2), 2327-2345. doi:10.3390/ijms1502232782.
Bensalem, S., Soubhye, J., Aldib, I., Bournine, L., Nguyen, A. T., Vanhaeverbeek, M., Rousseau, A., Zouaoui Boudjeltia, K., Sarakbi, A., Kauffmann, J.-M., Neve, J., Prévost, M., Stévigny, C., Maiza-Benabdesselam, F., Bedjou, F., Van Antwerpen, P., & Duez, P. (2014). Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). Journal of ethnopharmacology, 154(2), 361-369. doi:10.1016/j.jep.2014.03.07083.
Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmüller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reye, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Neve, J., Prévost, M., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (2013). Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. Journal of medicinal chemistry, 56(10), 3943-3958. doi:10.1021/jm400153884.
Cheel, J., Tumova, L., Areche, C., Van Antwerpen, P., Neve, J., Zouaoui Boudjeltia, K., San Martin, A., Vokral, I., Wsol, V., & Neugebauerova, J. (2013). Variations in the chemical profile and biological activities of licorice (Glycyrrhiza glabra L.), as influenced by harvest times. Acta Physiologiae Plantarum, 35(4), 1337-1349. doi:10.1007/s11738-012-1174-985.
Dequanter, D., Van de Velde, M., Nuyens, V., Nagy, N., Van Antwerpen, P., Vanhamme, L., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Brohée, D., & Lothaire, P. (2013). Assessment of oxidative stress in tumors and histologically normal mucosa from patients with head and neck squamous cell carcinoma: a preliminary study. European journal of cancer prevention, 22(6), 558-560. doi:10.1097/CEJ.0b013e32836056dc86.
Dequanter, D., Shahla, M., Zouaoui Boudjeltia, K., Paulus, P., & Lothaire, P. (2013). Neck and mediastinal node dissection in pharyngolaryngeal tumors. European annals of otorhinolaryngology, head and neck diseases, 130(1), 5-7. doi:10.1016/j.anorl.2012.04.00988.
Delporte, C., Van Antwerpen, P., Vanhamme, L., Roumeguere, T., & Zouaoui Boudjeltia, K. (2013). Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators of inflammation, 2013, 971579. doi:10.1155/2013/97157989.
Zouaoui Boudjeltia, K., Delporte, C., Van Antwerpen, P., Franck, T., Serteyn, D., Moguilevsky, N., Raes, M., Vanhamme, L., Vanhaeverbeek, M., Van Meerhaeghe, A., & Roumeguere, T. (2013). Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men. Mediators of inflammation, 2013, 750742. doi:10.1155/2013/750742